ACR 2015 The Crossroads of Radiology

ACR2015VM29 - Molecular Imaging in Dementia: Clinical Research to Clinical Translation

May 18, 2015 10:00am ‐ May 18, 2015 12:00pm


This session will provide attendees with information about new research in radiopharmaceuticals to evaluate dementia and with information about the use of molecular brain imaging in clinical trials of anti-Alzheimer's therapies. Attendees will develop a better understanding of the regulatory processes leading to translation of amyloid-binding radiopharmaceuticals into the clinic. This information will help attendees make their facilities referral sites for amyloid imaging in clinical trials. 

Subspecialties: MI, NU
Modalities: NM



  • Consultant: Hamamatsu Photonics; Royalty Income: GE Healthcare; Research Grants: Hitachi Medical Corp, Phillips Healthcare, Nihon Medi Physics, Seattle Genetics, Astellas Pharma
  • Consultant: MIM Software Inc, Bayer Healthcare, Avid Radiophamraceuticals; Research Grants: GE Healthcare 
  • Ownership/Partnership: Molecular Neuroimaging, LLC -equity

You must be logged in and own this session in order to post comments.